Low molecular weight heparin (LMWH) is an anticoagulant injected subcutaneously or intravenously and acts via activation of antithrombin III which in turn inactivates thrombin and factor Xa to produce ...

DVT affects 1-2 per 1000 adult population per annum in Western societies. It may be associated with pulmonary embolism, and some patients may develop postthrombotic syndrome with swelling of the leg, ...

Investigations have shown that compared with unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) can improve the clinical outcomes of patients with ST-segment elevation myocardial ...

Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Early treatment with low-molecular-weight heparin (LMWH) reduces the risk for death in patients ...

Please provide your email address to receive an email when new articles are posted on . For prevention of venous thromboembolism after noncardiac surgery, direct oral anticoagulants may be preferred ...

Postoperative and preoperative start of low molecular weight heparin (LMWH) does not change the outcome of mortality or risk of reoperation in patients with hip fractures treated with osteosynthesis, ...

Researchers suggest conclusive answers to key questions on the benefits of low molecular weight heparin (LMWH) for cancer patients remain elusive - despite promising results from large studies. For ...

The increased pregnancy rate at relatively advanced maternal age has led to higher rates of thromboembolic disease (TED), complicating pregnancy. A new paper discusses low-molecular-weight heparin ...

Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial Patients with active cancer and a first episode of DVT treated ...

Patients with ST-segment elevation myocardial infarction (STEMI) benefit from treatment with aspirin and thrombolytic therapy; however, the conflicting findings of studies examining the effect of ...